These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

61 related articles for article (PubMed ID: 14014526)

  • 1. [The onset of chronic myeloid leukosis].
    BOUSSER J; CHRISTOL D; OUTZEKOVSKY G
    Nouv Rev Fr Hematol; 1962; 2():358-69. PubMed ID: 14014526
    [No Abstract]   [Full Text] [Related]  

  • 2. [Chronic myeloid leukosis treated with 1-4-dimethane sulfonyl oxybutane; secondary pancytopenia].
    LANGERON L; CROCCEL L; ROUTIER G; BOYAVAL M
    J Sci Med Lille; 1959 Mar; 77(3):123-7. PubMed ID: 13655267
    [No Abstract]   [Full Text] [Related]  

  • 3. [Immediate and remote results of treatment of patients with chronic myeloid leukosis with myelosan].
    GUREVICH LI
    Sov Med; 1960 Oct; 24():84-8. PubMed ID: 13709851
    [No Abstract]   [Full Text] [Related]  

  • 4. [CHRONIC MYELOID LEUKOSIS IN CHILDREN: 4 CASES].
    CHAPTAL J; JEAN R; IZARN P; BONNET H; NAVARRO M; EMBERGER JM
    Pediatrie; 1963; 18():641-56. PubMed ID: 14057978
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of chronic myeloid leukemia with 1, 4-butanediol dimethylsulfonyl ester (busulfan)].
    BEROVIC R; BUGARSKI M; KONECNI J
    Srp Arh Celok Lek; 1956 May; 84(5):571-84. PubMed ID: 13391224
    [No Abstract]   [Full Text] [Related]  

  • 6. Busulfan in the treatment of chronic myelocytic leukemia. The effect of long term intermittent therapy.
    HAUT A; ABBOTT WS; WINTROBE MM; CARTWRIGHT GE
    Blood; 1961 Jan; 17():1-19. PubMed ID: 13712355
    [No Abstract]   [Full Text] [Related]  

  • 7. [Treatment of chronic myeloid leukemia with myleran].
    DE VRIES SI
    Ned Tijdschr Geneeskd; 1958 Feb; 102(8):364-9. PubMed ID: 13541504
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of chronic myeloid leukemia with myleran].
    BOHINJEC J
    Medizinische; 1957 Feb; (7):262-3. PubMed ID: 13418211
    [No Abstract]   [Full Text] [Related]  

  • 9. [Myleran therapy of chronic myeloid leukemia].
    BELER B; ERGUN N
    Turk Tip Cemiy Mecm; 1958 Apr; 24(4):205-8. PubMed ID: 13592964
    [No Abstract]   [Full Text] [Related]  

  • 10. [Aplastic anemia following myleran treatment of chronic myeloid leukemia].
    VAN ESSER JG
    Ned Tijdschr Geneeskd; 1958 Feb; 102(8):379-81. PubMed ID: 13541507
    [No Abstract]   [Full Text] [Related]  

  • 11. [Myleran in chronic myeloid leukemia; importance of systematic maintenance therapy].
    CLOSON J; CONTENT M
    Rev Belg Pathol Med Exp; 1956 Nov; 25(5):413-30. PubMed ID: 13421050
    [No Abstract]   [Full Text] [Related]  

  • 12. [Bone marrow aplasia consecutive to myleran therapy of chronic myeloid leukemia].
    KHURGIN MI; KHASANOVA RI
    Probl Gematol Pereliv Krovi; 1959 Jan; 4(1):52-3. PubMed ID: 13645532
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of chronic myeloid leukemia by means of a new chemical antiblastic agent, 1-4-dimethylsulfonoxy-butane].
    ESTEVEZ RA
    Prensa Med Argent; 1958 Apr; 45(16):1644-9. PubMed ID: 13601527
    [No Abstract]   [Full Text] [Related]  

  • 14. [Data on an unusual acute transformation in a case of chronic myeloid leukemia following dimethylsulfonoxy-butane therapy].
    GIGANTE D
    Clin Ter; 1958 May; 14(5):469-85. PubMed ID: 13561522
    [No Abstract]   [Full Text] [Related]  

  • 15. [Early result of myleran therapy of chronic myeloid leukemias].
    PAWELSKI S; SOBCZYNSKA-CZECHOWSKA Z
    Pol Tyg Lek (Wars); 1957 Oct; 12(43):1650-4. PubMed ID: 13505287
    [No Abstract]   [Full Text] [Related]  

  • 16. [THE USE OF DOPAN AND MYELOSAN IN THE TREATMENT OF PATIENTS WITH CHRONIC MYELOLEUKEMIA].
    SPASSKII OV
    Sov Med; 1963 May; 26():30-3. PubMed ID: 14073326
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment of chronic myelocytic leukemia with myleran].
    KANZOW U; WOLFERS H
    Medizinische; 1957 Oct; 2(40):1460-1; discussion 1461-2. PubMed ID: 13482894
    [No Abstract]   [Full Text] [Related]  

  • 18. [Cytostatic prolonged therapy in chronic leukemia].
    KLIMA R; BEYREDER J; HERZOG E
    Wien Med Wochenschr; 1957 May; 107(18-19):368-71. PubMed ID: 13443328
    [No Abstract]   [Full Text] [Related]  

  • 19. Splenectomy and chronic myeloid leukaemia.
    Rolfe M
    Med J Zambia; 1980; 14(6):118. PubMed ID: 6944973
    [No Abstract]   [Full Text] [Related]  

  • 20. Reduced-intensity conditioning allogeneic blood stem cell transplantation with fludarabine and oral busulfan with or without pharmacokinetically targeted busulfan dosing in patients with myeloid leukemia ineligible for conventional conditioning.
    Martino R; Pérez-Simón JA; Moreno E; Queraltó JM; Caballero D; Mateos M; Sureda A; Cañizo C; Brunet S; Briones J; Vazquez L; Clopés A; San Miguel JF; Sierra J
    Biol Blood Marrow Transplant; 2005 Jun; 11(6):437-47. PubMed ID: 15931632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.